Medicare

Senate Finance Committee Chair Chuck Grassley told Inside Drug Pricing he wants Congress to require that drug makers disclose list prices for prescription drugs in television ads, coming a day after a federal court on Monday (July 8) ruled the Trump administration lacks authority under current law to regulate drug makers’ television ads.

HHS is looking for 15 stakeholders to join a department-wide quality summit to put together a Health Quality Roadmap as required by President Donald Trump’s recent executive order on price transparency.

Doctors’ groups and accountable care organizations recently praised Rep. Suzan DelBene’s (D-WA) legislation to eliminate beneficiary cost sharing tied to chronic care management codes, as the providers say getting rid of the payments will lead to more beneficiaries taking advantage of those services.

President Donald Trump is writing an executive order to ensure the United States pays no more than any other country for prescription drugs, he said Friday (July 5).

FDA on Monday (July 1) eliminated postmarket requirements that makers of HIV prevention drug Truvada and its generics provide training materials to health care professionals and educational information to consumers, due to evidence that most providers and at-risk individuals are aware of the risks of the drug and know how to use it properly.

The White House Office of Management and Budget on Friday (June 28) began its review of a final Medicare and Medicaid burden reduction rule that also now includes updates to hospital and critical access hospital requirements that CMS delayed finalizing earlier in June.

The White House Office of Management and Budget on Wednesday (June 26) finished a seven-month long review of a burden reduction rule aimed at nursing homes.

Kidney Care Partners calls for a legislative and regulatory overhaul of renal disease treatment, including changes to the Medicare end-stage renal disease prospective payment system, an expansion of the Medicare Kidney Disease Education benefit, an extension of Medigap access for those with kidney disease and an HHS study on the social, behavioral and biological factors that lead to the disease.

CMS on Friday (June 21) finalized a streamlined coverage policy for transcatheter aortic valve replacements that reduces the number of procedures required to start or maintain a TAVR program.